Abstracts tagged "Comorbidity and spondylarthritis"

Abstract Number: 2748 • 2016 ACR/ARHP Annual Meeting
Prevalence of Comorbidities in Patients with Axial Spondyloarthritis and Its Association with Aspects of the Disease
Maria Celeste Orozco¹, Ana Lizarraga², Graciela Betancur², Natalia Zamora¹, Fernando Andres Sommerfleck³, Emilce Schneeberger⁴ and Gustavo Citera⁴, ¹Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Reumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ³Rheumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁴Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
Background/Purpose: The presence of comorbidities in patients with rheumatic diseases affects functional capacity and quality of life, but also they can limit the therapeutic approach…
Abstract Number: 1058 • 2015 ACR/ARHP Annual Meeting
Prevalence of Comorbidities in Spondyloarthritis and Evaluation of Their Monitoring: Results of the International Cross-Sectional ASAS-Comospa Study
Anna Moltó¹, Adrien Etcheto¹, Désirée van der Heijde², Robert B. M. Landewé³, Filip van Den Bosch⁴, Maxime Dougados⁵ and on behalf of the ASAS-COMOSPA task force, ¹Paris Descartes University, Rheumatology Department, Cochin Hospital, AP-HP. INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité,, Paris, France, ²Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands, Leiden, Netherlands, ³Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, the Netherlands, Amsterdam, Netherlands, ⁴Univ Hosp, Ghent, Belgium, ⁵Université Paris René Descartes and Hôpital Cochin, Paris, France
Background/Purpose: Increased risk of cardio-vascular disease, and osteoporosis is documented in SpA. Some of these comorbidities (e.g. cardiovascular disease risk) are subject to recommendations, with…